Cartesian Therapeutics
RNAC
RNAC
98 hedge funds and large institutions have $245M invested in Cartesian Therapeutics in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 27 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
+3
Holders Change %
+3.16%
% of All Funds
1.73%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
16
Increased
38
Reduced
27
Closed
13
Calls
$5.25M
Puts
$1.36M
Net Calls
+$3.9M
Net Calls Change
+$4.11M
Top Buyers
| 1 |
Goldman Sachs
New York
|
$9.62M |
| 2 |
Nuveen Asset Management
Chicago,
Illinois
|
$8.39M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$9.42M |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
$3.72M |
| 5 |
BlackRock
New York
|
$28.2M |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
$0 |
| 2 |
BI
BVF Inc
San Francisco,
California
|
$10.8M |
| 3 |
Renaissance Technologies
New York
|
$1.29M |
| 4 |
Morgan Stanley
New York
|
$3.72M |
| 5 |
6CM
683 Capital Management
New York
|
$0 |
